Variant ID: 1-55529828-C-T

NM_174936.3(PCSK9):c.*571C>T

This variant was identified in 4 publications




Publications:


Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders.

Frontiers In Neuroscience
EM O'Connell, FW Lohoff
Publication Date: 2020

Variant appearance in text: rs662145
PMID: 32595449
View BVdb publication page



Polymorphisms in PCSK9, LDLR, BCMO1, SLC12A3, and KCNJ1 are Associated with Serum Lipid Profile in Chinese Han Population.

International Journal Of Environmental Research And Public Health
Z Li, T Zhao, X Tan, S Lei, L Huang, L Yang
Publication Date: 2019-09-02

Variant appearance in text: rs662145
PMID: 31480784
View BVdb publication page



The dual behavior of PCSK9 in the regulation of apoptosis is crucial in Alzheimer's disease progression (Review).

Biomedical Reports
Q Wu, ZH Tang, J Peng, L Liao, LH Pan, CY Wu, ZS Jiang, GX Wang, LS Liu
Publication Date: 2014-03

Variant appearance in text: rs662145
PMID: 24649090
View BVdb publication page



PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population.

Journal Of Lipid Research
I Postmus, S Trompet, AJ de Craen, BM Buckley, I Ford, DJ Stott, N Sattar, PE Slagboom, RG Westendorp, JW Jukema
Publication Date: 2013-02

Variant appearance in text: rs662145
PMID: 23300213
View BVdb publication page



Alternative transcript annotations:

Transcript cDNA Protein Consequence Exon Intron
ENST00000302118.5 c.*571C>T - 3_prime_UTR_variant 12/12 -
ENST00000490692.1 n.3196C>T - non_coding_transcript_exon_variant 8/8 -
NM_174936.4 c.*571C>T - 3_prime_UTR_variant 12/12 -
NR_110451.1 n.2257C>T - non_coding_transcript_exon_variant 10/10 -